Illness	Number of cases
Heart failure (I50.01)	17
Malignant neoplasm of bronchus and lung (C34.1)	11
Malignant neoplasm of prostate (C61)	10
Left ventricular failure unspecified (I50.14)	9
Malignant neoplasm of rectum (C20)	8
Malignant neoplasm of breast (C50.9)	8
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	8
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	8
Malignant neoplasm of liver and intrahepatic bile ducts - Intrahepatic bile duct carcinoma (C22.1)	6
Malignant neoplasm of pancreas - Malignant neoplasm of head of pancreas (C25.0)	6

Top 10 treatments

Treatment	Number
(9-984.b)	105
Interdisciplinary end-of-life care (8-982.1)	101
(9-984.8)	82
Uniform basic assessment in terminal care (1-774)	76
(9-984.7)	47
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	40
Insertion of a small tube (cannula) or catheter into another organ or tissue for the drainage of fluid (8-148.0)	27
Interdisciplinary end-of-life care (8-982.0)	22
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	16
Transfusion of blood plasma or plasma components or genetically engineered blood proteins (8-810.x)	15

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 3752

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Asthma bronchiale

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
24	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
17	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
16	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility